NovoCRF: Globally Normalized De Novo Peptide Sequencing on a Prefix-Mass Lattice

De novo peptide sequencing from tandem mass spectrometry is pivotal in proteomics, enabling identification of novel peptides without reference databases. While recent Transformer-based encoder-decoder models have achieved remarkable performance, we uncover a critical pathology in their inference dynamics. Through comprehensive feature scaling experiments, we demonstrate that existing auto-regressive peptide decoders tend to over-rely on generated-sequence priors while progressively under-utilizing fine-grained physical evidence from the input mass spectrum. This phenomenon leads to suboptimal results, where generated peptide sequences are biologically plausible yet not faithful to the input spectrum. To rectify this, we propose MemNovo, a training-free and plug-and-play mechanism that re-balances peptide and spectral contributions at inference time. MemNovo alleviates the information bottleneck by establishing a persistent spectral memory bank and injecting retrieved features directly into the final decoding stage via an ultra-conservative residual connection. Theoretical analysis confirms that this mechanism restores the mutual information between the decoder state and the raw spectrum. Extensive experiments on the Nine Species benchmark with two representative baselines, Casanovo and InstaNovo, demonstrate that MemNovo consistently improves both amino acid precision and peptide precision, achieving up to 39.1% relative improvement in peptide precision for Casanovo and up to 3.9% for InstaNovo, with negligible computational overhead.

The discovery of novel proteins relies on sensitive protein identification, for which de novo peptide sequencing (DNPS) from mass spectra is a crucial approach. While deep learning has advanced DNPS, existing models inadequately enforce the fundamental mass consistency constraint, that a predicted peptide's mass must match the experimental measured precursor mass. Previous DNPS methods often treat this critical information as a simple input feature or use it in post-processing, leading to numerous implausible predictions that do not adhere to this fundamental physical property. To address this limitation, we introduce DiffuNovo, a novel regressor-guided diffusion model for de novo peptide sequencing that provides explicit peptide-level mass control. Our approach integrates the mass constraint at two critical stages: during training, a novel peptide-level mass loss guides model optimization, while at inference, regressor-based guidance from gradient-based updates in the latent space steers the generation to compel the predicted peptide adheres to the mass constraint. Comprehensive evaluations on established benchmarks demonstrate that DiffuNovo surpasses state-of-the-art methods in DNPS accuracy. Additionally, as the first DNPS model to employ a diffusion model as its core backbone, DiffuNovo leverages the powerful controllability of diffusion architecture and achieves a significant reduction in mass error, thereby producing much more physically plausible peptides. These innovations represent a substantial advancement toward robust and broadly applicable DNPS. The source code is available in the supplementary material.

De novo peptide sequencing from tandem mass spectra is essential for identifying peptides without relying on reference databases. Despite advances in deep learning, accurate sequencing remains challenging because experimental spectra are often sparse, noisy, and incomplete, leaving informative b- and y-ion fragments unobserved. Existing methods attempt to recover this missing evidence via latent-space imputation before autoregressive decoding. However, they typically treat imputation as a fixed reconstruction task, without considering which missing fragments are most relevant to decoder errors. Moreover, existing peak representations do not explicitly model mass differences between peaks, despite their fundamental importance. We introduce GyroNovo, a framework with two main contributions. First, we use decoder errors observed during training to adapt the imputation objective, prioritizing fragments associated with frequent decoding errors. We further use the decoder error distribution to construct easy and hard augmented views of each spectrum, enabling the decoder to learn under varying degrees of spectral corruption and missing-fragment severity. Second, we introduce a mass-aware inductive bias into self-attention by using rotary embeddings to encode pairwise mass differences between spectral peaks. Together, these components align missing-fragment recovery with decoder behavior while explicitly incorporating the mass relationships that underlie peptide fragmentation. At inference time, GyroNovo retains a standard encoder-imputer-decoder architecture and requires neither additional inputs nor auxiliary search procedures. Experiments on NovoBench show gains of about 9 percentage points in peptide-level precision and 7 percentage points in amino-acid-level precision over the state-of-the-art baseline. Code: https://github.com/UBC-NLP/gyronovo.